Natl. Drug Code Directory
The revised 1985 two volume directory contains a list of approximately 34,000 Rx drug products marketed in the U.S. The first volume contains an alphabetical index by product name and the second volume contains numeric indices by drug class, by natl. drug code and an alphabetical index of Rx drug labelers. New edition now includes the NDA, ANDA, or form 5 number for approximately 40% of the listed drugs. The directory, prepared by FDA's Drug Listing Branch, is available from the Government Printing Office, (202) 783-3238. Price is $76/domestic, $95/foreign. Order number 917-00900000-7.
You may also be interested in...
DJO Global will buy Trilliant Surgical to further its ongoing expansion into the US foot and ankle market.
Ying Huang was named CEO as his predecessor came under investigation in China and as partner Janssen was getting closer to seeking US FDA approval for its lead CAR-T therapy.
In addition to agreeing to emergency use of the Oxford University/Astra Zeneca and Sinovac vaccines, Brazil's medicines regulator has also published good manufacturing practices certificates for Pfizer and Janssen vaccine. It has questions about the Sputnik V authorization request.